Regional Control of Head and Neck Melanoma With Selective Neck Dissection

被引:12
|
作者
Geltzeiler, Mathew [1 ]
Monroe, Marcus [1 ]
Givi, Babak [1 ]
Vetto, John [2 ]
Andersen, Peter [1 ]
Gross, Neil [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97239 USA
[2] Oregon Hlth & Sci Univ, Dept Surg, Div Surg Oncol, Portland, OR 97239 USA
关键词
LYMPH-NODE DISSECTION; MALIGNANT-MELANOMA; PROGNOSTIC-FACTORS; CUTANEOUS MELANOMA; LYMPHADENECTOMY; MANAGEMENT; EFFICACY; BIOPSY;
D O I
10.1001/jamaoto.2014.2056
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
IMPORTANCE Historically, patients with cervical metastases from melanoma of the head and neck were treated with a radical neck dissection. This study evaluates the efficacy of limiting the extent of lymphadenectomy in this high-risk population. OBJECTIVES To determine whether limiting the extent of lymphadenectomy for patients with biopsy-proven melanoma has a negative effect on regional control. Our hypothesis was that performing a more limited lymphadenectomy does not have a negative impact on regional control. DESIGN, SETTING, AND PARTICIPANTS A retrospective, single-cohort study was performed using a prospectively collected database of patients with head and neck melanoma with histopathologically positive lymph nodes after modified radical (MRND) or selective neck dissection (SNDs) performed at a high-volume, academic, tertiary care center. INTERVENTIONS Lymphadenectomy was performed as clinically indicated. MAIN OUTCOMES AND MEASURES Primary end points were regional recurrence and regional recurrence free survival. Univariable and multivariable analyses were conducted using multiple patient characteristics. RESULTS Forty-one patients underwent SND or MRND from 2001 through 2010. The median number of positive nodes was 1 (range, 1-16). Twenty-six patients (63%) received adjuvant radiation and 23 patients (56%) received adjuvant immunotherapy or chemotherapy. The median follow-up time was 17 months (range, 1-116 months). Regional control was achieved in 29 patients (71%). Median regional recurrence-free survival was 21 months (range, 1-116 months). Age (hazard ratio [HR], 1.13; 95% CI, 1.01-1.26), total number of nodes examined (HR, 1.05; 95% CI, 1.01-1.10), and number of sentinel lymph nodes examined (HR, 1.45; 95% CI, 1.01-2.09) were all significantly associated with increased recurrence-free survival. Tumor depth, extracapsular spread, number of nodes positive, prior SLNB, extent of lymphadenectomy, and adjuvant therapy were not significant. CONCLUSIONS AND RELEVANCE Limiting the extent of lymphadenectomy with frequent use of adjuvant radiation therapy is effective in achieving regional control of head and neck melanoma with cervical metastases.
引用
收藏
页码:1014 / 1018
页数:5
相关论文
共 50 条
  • [21] Results of selective neck dissection in the management of head and neck squamous cell carcinoma
    Schmitz, S.
    Vandervorst, S.
    Beguin, C.
    Ledeghen, S.
    Desuter, G.
    Gregoire, V.
    Hamoir, M.
    RADIOTHERAPY AND ONCOLOGY, 2007, 82 : S75 - S75
  • [22] Role of Sentinel Biopsy or Neck Dissection in Malignant Melanoma of the Head-Neck Region
    Wilder, D.
    Krimmel, M.
    Haefner, H. M.
    Breuninger, H.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 (09): : 760 - 760
  • [23] Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck
    Bonnen, MD
    Ballo, MT
    Myers, JN
    Garden, AS
    Diaz, EM
    Gershenwald, JE
    Morrison, WH
    Lee, JE
    Oswald, MJ
    Ross, MI
    Ang, KK
    CANCER, 2004, 100 (02) : 383 - 389
  • [24] Regional relapse in selective neck dissection more frequent
    Franke, Katharina
    Duenne, Anja-A
    Maune, Steffen
    LARYNGO-RHINO-OTOLOGIE, 2006, 85 (06) : 405 - 407
  • [25] Selective neck dissection in the treatment of head and neck squamous cell carcinoma patients with a clinically positive neck
    Lopez, Fernando
    Fernandez-Vanes, Laura
    Garcia-Cabo, Patricia
    Grilli, Gianluigi
    Alvarez-Marcos, Cesar
    Luis Llorente, Jose
    Pablo Rodrigo, Juan
    ORAL ONCOLOGY, 2020, 102
  • [26] Management of Regional Lymph Nodes in Head and Neck Melanoma
    Glaun, Mica D. E.
    Feng, Zipei
    Lango, Miriam
    ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA, 2022, 34 (02) : 273 - 281
  • [27] VALUE OF ELECTIVE LYMPH MODE DISSECTION IN HEAD AND NECK MELANOMA
    BALM, AJM
    KROON, BBR
    GREGOR, RT
    HILGERS, FJM
    DIAGNOSTIC ONCOLOGY, 1993, 3 (05): : 263 - 267
  • [28] Handling of neck dissection in head and neck tumours
    Baglin, Anne-Catherine
    ANNALES DE PATHOLOGIE, 2009, 29 (04) : 361 - 364
  • [29] Neck dissection and chemoradiation in head and neck cancer
    Thariat, Juliette
    Marcy, Pierre-Yves
    LANCET ONCOLOGY, 2010, 11 (03): : 224 - 225
  • [30] ELECTIVE NECK DISSECTION IN HEAD AND NECK CANCER
    SKOLNIK, EM
    TENTA, LT
    TARDY, ME
    WINEINGER, DM
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1968, 87 (05) : 471 - +